DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,900
-100 (-0.67%)
Mar 28, 2025, 3:30 PM KST
-11.94%
Market Cap 655.13B
Revenue (ttm) 812.17B
Net Income (ttm) 60.77B
Shares Out 43.97M
EPS (ttm) 1,368.41
PE Ratio 10.89
Forward PE 9.61
Dividend 200.00 (1.34%)
Ex-Dividend Date Dec 27, 2024
Volume 83,926
Average Volume 196,026
Open 15,000
Previous Close 15,000
Day's Range 14,750 - 15,000
52-Week Range 14,400 - 20,600
Beta 0.59
RSI 38.79
Earnings Date Mar 7, 2025

About DongKook Pharmaceutical

DongKook Pharmaceutical Co., Ltd. produces and sell pharmaceutical products in South Korea and internationally. The company offers non-prescription and prescription drugs, quasi drugs, medical devices, active pharmaceutical ingredients, and cosmetics. Its pipeline includes DKF-310, which is in preclinical trials for the treatment of dementia; DKM-413, used for anesthetic; DKF-361, used to treat hypertension; DKF-325, an anticoagulant; DKM-412 and DKM-420 to treat osteoarthritis; DKF-313, that is in clinical studies, indicated for benign prostat... [Read more]

Sector Healthcare
Founded 1968
Employees 1,131
Stock Exchange KOSDAQ
Ticker Symbol 086450
Full Company Profile

Financial Performance

In 2024, DongKook Pharmaceutical's revenue was 812.17 billion, an increase of 11.10% compared to the previous year's 730.99 billion. Earnings were 60.77 billion, an increase of 29.92%.

Financial Statements

News

There is no news available yet.